Colorescience, a well-regarded skincare and sun protection brand, has recently been acquired by RoundTable Healthcare Partners, marking a significant development in the beauty industry. Although details regarding the financial terms of the deal have not been disclosed, industry insiders suggest that Colorescience is approaching impressive annual sales figures close to $100 million. The brand, previously managed by a group of shareholders led by 1315 Capital, has established itself as a trusted name in skincare, reflecting a commitment to delivering effective protection and exceptional performance for its customers.
Reflecting on this pivotal moment, Mary Fisher, the CEO of Colorescience, expressed her gratitude to the team for their unwavering passion and dedication. Since its inception in 2013, Colorescience has grown significantly under her leadership. Fisher emphasized her excitement over partnering with RoundTable as they transition into the next phase of the company’s evolution, highlighting that the values and culture of RoundTable closely align with what makes Colorescience unique. This collaboration is seen as a promising synergy aimed at propelling the brand to new heights in the competitive skincare market.
Underlining the strengths that attracted RoundTable to Colorescience, Tim Connors, managing partner of RoundTable and chairman of Colorescience’s board, spoke of the brand’s strong consumer advocacy and its distinct product portfolio. He noted that Colorescience is anchored by a commitment to science and innovation, which positions it firmly in a market that increasingly values efficacy and trusted ingredients. Their focus on delivering products that are not only effective but also safe for consumers has cultivated a loyal customer base that is likely to continue growing.
The journey of Colorescience, which debuted over 25 years ago, showcases a captivating evolution. Initially owned by SkinMedica, the brand eventually became a part of a diverse portfolio before being guided by the vision of 1315 Capital. Throughout the years, Colorescience has maintained a clear mission: to protect and enhance the skin’s appearance while ensuring the products remain credible and scientifically backed. This enduring commitment to quality has allowed them to carve a niche in the sun protection and skincare markets, enabling the brand to expand its reach and influence.
Adele Oliva, a founding partner at 1315 Capital, shared her reflections on the partnership with Colorescience, highlighting the rewarding experience it has been to work alongside such a dedicated team. Colorescience’s impactful mission, focused on protecting and saving lives through advanced skin care products, resonated deeply with Oliva and her team. She voiced enthusiasm for RoundTable’s involvement, expressing confidence that their operational expertise and focus would drive Colorescience’s growth further in the future. This trust in RoundTable’s capabilities underscores the expected next chapter in the company’s narrative.
As Colorescience embarks on this exciting new era, the potential for growth and innovation appears promising. With their established reputation, commitment to scientific advancement, and now, the backing of RoundTable Healthcare Partners, Colorescience is well-positioned to navigate the evolving landscape of skincare and sun protection. As the industry continues to respond to consumer demands for transparency and effectiveness, Colorescience’s journey seems set to inspire both employees and consumers alike, reinforcing its status as a leader in the market.
